KOR

e-Article

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the NeoCheckRay trial
Document Type
Article
Source
In: Journal for ImmunoTherapy of Cancer. (Journal for ImmunoTherapy of Cancer, 6 December 2023, 11(12))
Subject
Language
English
ISSN
20511426